within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BB09_IbandronicAcidAndColecalciferol;
model IbandronicAcidAndColecalciferol 
   extends Pharmacolibrary.Drugs.ATC.M.M05BB09;

  annotation(Documentation(
    info ="<html><body><p>Ibandronic acid and colecalciferol is a combination medication used in the management of osteoporosis; ibandronic acid is a bisphosphonate that inhibits bone resorption, while colecalciferol (vitamin D3) aids calcium absorption. The drug is approved and in use for prevention and treatment of osteoporosis, primarily in postmenopausal women.</p><h4>Pharmacokinetics</h4><p>No clinical pharmacokinetic studies specifically reported for the fixed combination product of oral ibandronic acid and colecalciferol; parameter values are estimated based on published data for each individual active substance in healthy adult women.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end IbandronicAcidAndColecalciferol;
